NurExone Biologic (TSXV: NRX) (Germany: J90)

Over the past year, the term "exosome" entered mainstream conversation, but much of the visibility came from cosmetic or plant-derived products. The next phase looks very different. Do you agree that 2026 marks the shift to therapeutic reality for exosomes?

Welcoming Eyal Gabbai to our Board! He brings a strong mix of patient perspective, health-system economics and capital markets experience to help translate strong science into real-world care. Read more: globenewswire.com/news-release/2…

⚡ NurExone’s exosomes show significant anti-inflammatory activity, outperforming commercial alternatives in new laboratory analysis! #Biotech #Exosomes #RegenerativeMedicine #Innovation #NurExone $NRX Read here: lnkd.in/er_dyYRs

🗞️ Planning Small-Scale ExoPTEN Clinical Manufacturing in Preparation for Future First-in-Human Use Pathways! #NurExone #ExoPTEN #Exosomes #Biomanufacturing #ClinicalReadiness Read more: lnkd.in/dd9qjaCu

@ABCWorldNews @ReeveWill Christopher Reeve really was a Super Man who inspires us with his legacy for patients with spinal cord injuries as we work towards new therapeutic directions

In his new primetime special, 'Finding My Father,' @ReeveWill revisits the last expedition taken by his late father, Christopher Reeve, before a horseback riding accident left him paralyzed in 1995, and retraces his footsteps alongside gray whales. abcnews.link/YQISiu2

We released our Q3 results and corporate updates on Friday, highlighting scientific progress, strengthened IP, and continued momentum toward clinical readiness. Read more: lnkd.in/du39EqS8

NurExone was nominated for The Galien Foundation Best Bridge Builder Award as we bridge academic research and applied innovation. #SeeyouinStockholm #GalienPrix #BridgeBuilding prnewswire.com/news-releases/…

NurExone Biologic is pioneering a class of regenerative medicines that harness the body's own communication system to develop therapies with the potential to regenerate, repair & restore nerve function! #Exosomes #ExoTherapy #BiotechInvesting #SpinalCord

The Jerusalem Post highlighted ScienceAbroad’s work connecting thousands of Israeli scientists worldwide, advancing collaboration, mentorship, and the global exchange of ideas. Thank you Judy Siegel-Itzkovich for the wonderful coverage! 📖 Read here: jpost.com/science/articl…

Not easy to pick up where nature leaves off, but we are trying our best! Learn more!!

Read more about NurExone's Regenerative Therapy for CNS injuries under development: advancingrna.com/doc/developing…

clinicaltrialvanguard.com/executiveinter… Learn about NurExone and regenerative medicine in this great piece!

🧠 “Reproducibility is the key challenge in science, and now we have a first validation confirming that ExoPTEN has the potential impact of a true therapeutic.” — Prof. Michael Belkin, Scientific Advisor to NurExone Read More: globenewswire.com/news-release/2…

Shana Tova!

Q. Why Indiana? A. Because it’s #1 in U.S. life-sciences exports (2024) and generates $99 B in annual economic output. globenewswire.com/news-release/2… #Exosomes #RegenerativeMedicine #Biotech #Indiana #Manufacturing #NurExone #Growth #LifeSciences

Three corporate updates: globenewswire.com/news-release/2…